News

Hydroxychloroquine Debate Rages in Federal Medicine


 

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, and one of the main spokespersons for science in the hydroxychloroquine debate, has continued to try to make his concerns clear: “I think we’ve got to be careful that we don’t make that majestic leap to assume this is a knockout drug,” he said in late March. “We still need to do the kinds of studies that definitively prove whether any intervention—not just this one, any intervention—is truly safe and effective.”

Pages

Recommended Reading

Managing gynecologic cancers during the COVID-19 pandemic
Covid ICYMI
COVID-19 causes financial woes for GI practices
Covid ICYMI
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
Covid ICYMI
COVID-19 pandemic brings unexpected pediatric consequences
Covid ICYMI
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
Covid ICYMI
Remdesivir tops list of promising COVID-19 treatments in review of nearly 300 trials
Covid ICYMI
What do early remdesivir data suggest?
Covid ICYMI
CMS loosens clinician scope-of-practice, telehealth rules for COVID-19 crisis
Covid ICYMI
SARS-CoV-2 may confound seasons, persist in warmer months, report shows
Covid ICYMI
AMA asks HHS for ‘immediate’ aid to ease clinicians’ COVID-19 ‘financial peril’
Covid ICYMI

Related Articles